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Abstract
The aim of the research was analyze of C-reactive protein levels in serum blood samples during various periods of pregnancy 
in women, infected with parvovirus B19 and in case of presence of clinical complications.
129 pregnant women, infected with parvovirus B19 infection and 16 women with physiological pregnancy during first, sec-
ond and third trimesters of pregnancy were examined. Depending on the presence or absence of clinical complications each group of 
pregnant women (I, II, III) was divided into two subgroups. The concentration of C-reactive protein in blood serum was determined 
by the method of immunoassay analysis using diagnostic sets of reagents (ELISA kits, USA). Statistical processing of data was car-
ried out using the package of applied programs Microsoft Office Excel 2010 and StatSoft Statistica 6.1.
The mean age of pregnant woman in our study was 26±6 years. In the Iand II groups of infected B19 parvovirus pregnant 
women were identified a significant increasing of C-reactive protein levels compared to controls by 62.5 % and 50.0 % (p<0.05). 
The largest increasing of C-reactive protein level relative to control values was observed in women with clinical complications in 
different pregnancy periods (p<0.05).
An increase levels of the marker of systemic inflammation the C-reactive protein in the blood testifies to its active partici-
pation in the launch of a complex mechanism for the development of labor activity and the occurrence of fetal disorders, which was 
confirmed in groups of pregnant women with clinical complications in different periods of pregnancy.
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1. Introduction
Among the factors which have bad influence on pregnancy, virus infections are one 
of the most important. Fetal viral infection can cause fetal death, undeveloped pregnancy or 
miscarriage. Usually these pathologies are associated with acute respiratory viral infections, 
influenza, measles, parotitis, poliomyelitis, acute Coxsackie viral infection. Parvovirus infec-
tion in pregnancy – acute viral infection caused by parvovirus B19 (Primate erythro parvovi-
rus) and characterized by a variety of clinical manifestations. Nowadays the role of systemic 
inflammatory process in the physiology andpathology of pregnancy becomes more important. 
Most of the inflammatory reactions are localized in the area of damage, particularly in tissues 
of the endo- and myometrium (that is a result of trophoblast invasion), but in some cases sys-
tematic inflammatory response can happen. C-protein is diagnostic marker, which indicates 
the presence of inflammatory processes in the body of pregnant women [1]. An increase of the 
CRP level above 8 mg/L indicates the risk of pregnancy loss. Systemic inflammatory response 
during physiological pregnancy is caused by genetic “foreignness” of fetus, but the reason of 
pathologic pregnancy is the decompensation of systems that regulate systemic inflammatory 
response [2]. Role of CRP is not only binding the components of microorganisms and toxins, 
but also binding of cytokines, IL-4, TGFβ, which possess suppressive properties. Therefore, 
it could facilitate the switching of the immune response from humoral to cellular. When con-
nected to any of the ligands, CPR acquires the ability to activate the complement (both in 
classical and alternate way). Also, CRP can bind to lymphoid cells, playing with phagocytes 
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and platelets the role of an immune modulator. By activating the complement and all dependent 
reactions (adhesion, chemotaxis, phagocytosis) and modulating the activity of immunocompe-
tent cells and platelets, the CRP carries out the connection between the various components of 
the inflammatory process. Therefore, the main role of CRP is recognising various substances 
presented on microorganism’s cells or human tissues surfaces, activation of the corresponding 
functional systems and, consequently, elimination of pathogens, as well as “old” and necro-
tized cells of the body.Nowadays the role of systemic inflammatory process in the physiology 
andpathology of pregnancy becomes more important. System inflammatory response during 
a normal pregnancy occurs because of an effect of «extraneous body», which is a result of 
normal difference between mother and fetus genotypes. In case of decompensation of sys-
tem controlling the inflammatory response may cause pathological course of pregnancy [3]. 
C-reactive protein (hs-CRP) is a blood test marker for inflammation in the body of pregnant 
women [4]. In most of cases inflammatory centers are located in places of damage of endo- and 
myometrium during trophoblast invasion [5, 6], but sometimes occurs general inflammation. 
During the normal pregnancy levels of hs-CRP can increase up to 3 mg/l, if hs-CRP increases 
over 8 mg/l it enhances probability of premature delivery in two times. High levels of hs-CRP 
from 5 to 19 weeks of pregnancy can lead to spontaneous abortion [7, 8].
Increased hs-CRP levels during pregnancy are often associated with poor pregnancyout-
comes, such as preeclampsia [9, 10], fetal growth retardation syndrome andintrauterine infec-
tion [11]. Hs-CRP is one of the early components, which can protect from infection [12, 13]. Just 
2–4 hours after invasion, the level of hs-CRP increases, that lead to stimulation ofimmune re-
actions, such as phagocytosis, induction of pro-inflammatory cytokines(IL-1, IL-6, TNF-a) [14], 
monocyte tissue factor and activation of classicalcomplement pathway. Therefore, hs-CRP is con-
sidered as the most sensitive andrapid indicator of tissue damage during inflammatory process 
and it helps to detecteven minimal inflammation, and make faster diagnostic process for using the 
optimal treatment strategy [15, 16].
Approximately 30 % of pregnant women have no immunity to parvovirus B19infection. 
Frequency of infection during the pregnancy is near 0.4–3.7 %, and itmay cause spontaneous 
abortion (5–8 %) or intrauterine fetal infection leading tomal formations [17]. Pregnant women 
more often have asymptomatic course ofparvovirus infection (60 % of cases). Subclinical forms 
of parvovirus disease appear much more often than manifestation forms [18, 19]. Therefore, 
more often pregnant womenhave retrospective thoughts about acute parvovirus infection, when 
appears disordercommon for parvovirus B19 – “non-immune fetal hydrops” [20]. It is a reason, 
why hs-CRP test is needed for diagnostic of subclinical forms of parvovirus infectionbetween 
patients with premature delivery [21, 22], preterm labor or presence of clinicalcomplications.
2. Aimof research
To analyze of hs-CRP levels in serum blood samples during various periods ofpregnancy in 
women, infected with parvovirus B19 and in case of presence ofclinical complications.
3. Materials and methods
On the basis of the Perinatal Center of Kiev, pregnant women were tested for the presence 
of parvovirus infection in the 2012–2017period. 129 pregnant women, infected with parvovirus 
B19 infection (from 19 to 39years old, mean age – 26±6 years) were examined in the research. 
Patients weredivided into three groups (groups І, ІІ, ІІІ) depending of a period of gestation. 
Subgroups of pregnant women without clinical complications were named as Іa, ІІa and ІІІa. 
Subgroups with complications named as Іb, ІІb and ІІІb. 16 woman formed the control group 
with physiological course of pregnancy in different trimesters. The concentration of hs-CRP in 
blood serum was determined by the method of immunoassay analysis using diagnostic sets of 
reagents (ELISA kits, USA).
The statistical processing of the obtained results was carried out using standard methods 
of variation statistics, taking into account the differences in the Student t criterion, which was 
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estimated using the confidence probability (p) less than 0.05 using Microsoft Office Excel 2010 for 
Windows and StatSoftStatistica6.1. The results are described as M±m. [23].
4. Results of research
From 129 pregnant women with parvovirus infection 57 (44.2 %) of them had increased lev-
els of hs-CRP (exceeding was 20 % from control level in currenttrimester). Infected patients from 
І and ІІ groups showed significant increasing of hs-CRP levels comparatively with woman from 
control group: 62.5 % and 50.0 %,respectively (Table 1). Levels of hs-CRP of pregnant women 
from group III haddifference from the control group just on 29.8 % (р<0.05).
Table 1
Levels of hs-CRP in blood serum of pregnant B19-infected women in different trimesters
Trimester 
groups
Level of hs-CRP, mg/l (n=145), М±m
Control group, 
n Healthy Main Groups n Infected Δ, %
І trimester 
(n=50) 5 5.6±0.8 І 45 9.1±1.4* +62.5
ІІ trimester 
(n=54) 6 6 5.4±0.5 ІІ 48 8.1±1.0* +50.0
ІІІ trimester 
(n=36) 5 5 4.7±0.9 ІІІ 36 6.1±1.0 +29.8
Note: * – р<0.05 compared to a group of healthy pregnant women; Δ – difference compared with data from healthy pregnant 
women
Pregnant women from the main group according to the trimester of pregnancy were di-
vided into subgroups: without clinical complications are grouped into Ia, IIa, IIIa subgroups and 
withclinical complications during pregnancy – in the Ib, IIb, and ІІIb subgroups.
Comparing subgroups of pregnant infected women with or without complications showed 
significant increasing of hs-CRP in groups Ib, IIb, IIIb (Table 2).
Table 2
Levels of hs-CRP in blood serum of pregnant B19-infected women with (groups «b») or without (groups «a») 
clinical complications
Trimester 
groups
Level of hs-CRP, mg/l (n=145), М±m
n Healthy Groups n Infected Δ, %
І trimester 
(n=50) 5 5.6±0.8
Іa 
Іb
6 
39
7.21.3 
9.41.6±*
+28.6 
+67.8
ІІ trimester 
(n=54) 6 5.4±0.5
ІІa 
ІІb
19 
29
6.7±1.2 
9.1±0.9*
+24.1 
+68.5
ІІІ trimester 
(n=41) 5 4.7±0.9
ІІІa 
ІІІb
30 
6
5.8±1.2 
7.9±0.6*
+23.4 
+68.1
Note: * – р<0.05 compared to a group of healthy pregnant women; Δ – difference compared with data from healthy pregnant 
women
Levels of hs-CRP from all groups of B19-infected pregnant women without complications 
showed almost the same difference with the control group, this difference in groups Ia–IIIa was 
from 23.4 % to 28.6 %. But in groups with complications (Ib–IIIb) this difference was between 
67.8 % and 68.1 % (Fig. 1). 
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Fig. 1. Comparison content of levels of hs-CRP in groups of B19 infected pregnant women  
Ia–IIIa (without complications) with groups Ib–IIIb( with clinical complications)
5. Discussion
The present research of levels of hs-CRP has established a moderate increasing its con-
centration in the blood serum of pregnant women with parvovirus B19 infection, which is 
connected with slight damage of tissues. It is well-known, that hs-CRP can stimulate inflam-
matory response by activating of classical complement pathway, tissue damage and induction 
of pro-inflammatory cytokines in monocytes [10]. Those factors can cause adverse pregnancy 
outcomes. Current study shows, that parvovirus B19 infection during pregnancy is related with 
increasing of hs-CRP on all gestation periods. Significant increasing of hs-CRP level can ac-
tivate phagocytes. Absorption of protein by neutrophils leads to hs-CRP proteolysys, it causes 
releasing of immunoactive low weight peptides that can modulate the functions of neutrophils, 
monocytes and macrophages (increases chemotaxis of phagocytes, production of superoxide 
anion and IL-1). In monocytes hs-CRP enhances the generation of active forms of oxygen and 
tumor necrosis factor-a. Additionally, hs-CRP affects other immune competent cells: hs-CRP 
can connect with T-helper cells, cytotoxic T-lymphocytes and NK-cells (also, NK-cells, can 
produce CRP by themselves).
It is known that CPR can exacerbate inflammatory responses through complement activa-
tion, tissue damage, and induction of inflammatory cytokines in monocytes thus lead to adverse 
pregnancy outcomes. Results of current study show that parvovirus infection during pregnancy 
is connected with increased levels of CRP on all terms of pregnancy. Significant increase in the 
level of CRP may provoke activation of phagocytic cells. Absorption of protein by neutrophils 
leads to CRP proteolysys, which results in the isolation of immunoactive low molecular weight 
peptides that can modulate the functions of neutrophils and monocytes/macrophages (increased 
chemoacusis of phagocytes, production superoxide anion and interleukin-1). In monocytes, CRP 
increases the generation of active forms of oxygen, factor TNF-α. In addition, CRP affects other 
immunocompetent cells: it can bind T-helper cells, cytotoxic T-lymphocytes, NK-cells (also, NK-
cells, can produce CRP by themselves). CRP is the most sensitive and fastest indicator of tissue 
damage during inflammation. Pregnant women with high levels of C-reactive protein (CRP) in the 
blood are at high risk for preterm delivery. Increasing level of CRP is able to provoke the activation 
of phagocytic cells in various intensity. Free CRP is absorbed by neutrophils in large amounts and 
is rapidly internationalized. The result of CRP proteolysys in the phagosomes of neutrophils is the 
secretion of immunoactive low molecular weight peptides that can modulate the functions of neu-
trophils and monocytes/macrophages: enhance chemoacusis of phagocytes, their production of su-
peroxide anion and IL-1. Monocytes not only bind CRP, but also synthesize it. In monocytes, CRP 
enhances the generation of active forms of oxygen, thereby increasing the ability of macrophages 
to synthesize TNF-α. So, effect of CRP on monocytes has a more pro-inflammatory character 
than in the case of neutrophils, when the result of influence depends on the stage of inflammation 
and activity of neutrophils. In addition, CRP affects other immunocompetent cells: it can bind to 
lymphocytes (CD4 +, CD8 +), NK cells. Synthesis and secretion of CRP is regulated by cytokines: 
IL-6, IL-1 and TNF-α. 
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Therefore, the growth of the marker of systemic inflammation response - C-reactive protein, 
indicates an active participation in the launch of a complex mechanism of the development of fetal 
and pregnancy disorders, which was confirmed in groups of women with clinical complications in 
different periods of pregnancy.
6. Conclusions
1. An increased level of the marker of systemic inflammation hs-CRP in the blood serum 
testifies to its active participation in the launch of a complex mechanism for the development of 
labor activity and the occurrence of fetal disorders, which was confirmed in groups of pregnant 
women with clinical complications in different pregnancy periods.
2. Significant growth (in 1.6 and 1.5 times) of the sensible marker of systemic inflammation 
of C-reactive protein in infected pregnant women in the 1st and 2nd trimesters was found, the most 
significant in women with clinical complications of pregnancy and to the same extent (in 1.7 times) 
in different trimesters of pregnancy.
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Abstract
The article presents data on the change in the cellular composition of the lymph nodes of the white rats, males of reproductive 
age, who received intramuscular opioid analgesics – nalbuphine every day for six weeks. The weekly dose of nalbuphine was grad-
ually increased, creating a model of physical opioid dependence according to the patent of Ukraine No. 76564 U. All experimental 
animals were divided into 8 groups.
Morphometric method was used to determine the relative number of cells of the lymphoid series – small, medium and large 
lymphocytes, blasts and plasmocytes in the cloak zone and the embryonic center of the secondary lymphoid nodes and brain strands 
of the lymph nodes. Morphometric studies were performed using a system of visual analysis of histological preparations. 
